Trastuzumab deruxtecan in HER2-low breast cancer - The authors reply Correspondence

  

Authors:	Modi, S.; Gambhire, D.; Cameron, D.
Title:	Trastuzumab deruxtecan in HER2-low breast cancer - The authors reply
Keywords:	camptothecin; breast neoplasms; breast tumor; trastuzumab; antibody conjugate; immunoconjugates; humans; human; female; trastuzumab deruxtecan
Journal Title:	New England Journal of Medicine
Volume:	387
Issue:	12
ISSN:	0028-4793
Publisher:	Massachusetts Medical Society
Date Published:	2022-09-22
Start Page:	1145
End Page:	1146
Language:	English
DOI:	10.1056/NEJMc2210368
PUBMED:	36130006
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138254932&doi=10.1056%2fNEJMc2210368&partnerID=40&md5=f439ba4d730f3e8e24fe16f63e0c637b
Notes:	Letter -- Export Date: 3 October 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/198209